| The risk of extra‐colonic, extra‐endometrial cancer in the Lynch syndrome P Watson, HFA Vasen, JP Mecklin, I Bernstein, M Aarnio, HJ Järvinen, ... International journal of cancer 123 (2), 444-449, 2008 | 740 | 2008 |
| Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database P Møller, TT Seppälä, I Bernstein, E Holinski-Feder, P Sala, DG Evans, ... Gut 67 (7), 1306-1316, 2018 | 615 | 2018 |
| Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database M Dominguez-Valentin, JR Sampson, TT Seppälä, SW Ten Broeke, ... Genetics in Medicine 22 (1), 15-25, 2020 | 612 | 2020 |
| Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database P Møller, T Seppälä, I Bernstein, E Holinski-Feder, P Sala, DG Evans, ... Gut 66 (3), 464-472, 2017 | 598 | 2017 |
| Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ... Jama 313 (13), 1347-1361, 2015 | 595 | 2015 |
| A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general … AC Antoniou, X Wang, ZS Fredericksen, L McGuffog, R Tarrell, ... Nature genetics 42 (10), 885-892, 2010 | 409 | 2010 |
| Identification of six new susceptibility loci for invasive epithelial ovarian cancer KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ... Nature genetics 47 (2), 164-171, 2015 | 323 | 2015 |
| High proportion of large genomic deletions and a genotype–phenotype update in 80 unrelated families with juvenile polyposis syndrome S Aretz, D Stienen, S Uhlhaas, M Stolte, MM Entius, S Loff, W Back, ... Journal of medical genetics 44 (11), 702-709, 2007 | 280 | 2007 |
| Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction AC Antoniou, J Beesley, L McGuffog, OM Sinilnikova, S Healey, ... Cancer research 70 (23), 9742-9754, 2010 | 259 | 2010 |
| Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores J Lecarpentier, V Silvestri, KB Kuchenbaecker, D Barrowdale, J Dennis, ... Journal of Clinical Oncology 35 (20), 2240-2250, 2017 | 200 | 2017 |
| Does fetal antigen 1 (FA1) identify cells with regenerative, endocrine and neuroendocrine potentials? A study of FA1 in embryonic, fetal, and placental tissue and in maternal … C Floridon, CH Jensen, P Thorsen, O Nielsen, L Sunde, JG Westergaard, ... Differentiation 66 (1), 49-59, 2000 | 200 | 2000 |
| Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database P Møller, T Seppälä, I Bernstein, E Holinski-Feder, P Sala, DG Evans, ... Gut 66 (9), 1657-1664, 2017 | 161 | 2017 |
| Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers AC Antoniou, OM Sinilnikova, L McGuffog, S Healey, H Nevanlinna, ... Human molecular genetics 18 (22), 4442-4456, 2009 | 151 | 2009 |
| Localization of E-cadherin in villous, extravillous and vascular trophoblasts during intrauterine, ectopic and molar pregnancy C Floridon, O Nielsen, B Hølund, L Sunde, JG Westergaard, SG Thomsen, ... MHR: Basic science of reproductive medicine 6 (10), 943-950, 2000 | 151 | 2000 |
| von Hippel-Lindau disease (vHL) ML Binderup, ML Bisgaard, V Harbud, HU Møller, S Gimsing, ... National clinical guideline for diagnosis and surveillance in Denmark. 3rd …, 2013 | 129 | 2013 |
| A genome-wide scan in affected sibling pairs with idiopathic recurrent miscarriage suggests genetic linkage AM Kolte, HS Nielsen, I Moltke, B Degn, B Pedersen, L Sunde, ... Molecular human reproduction 17 (6), 379-385, 2011 | 121 | 2011 |
| Risk‐reducing mastectomy and salpingo‐oophorectomy in unaffected BRCA mutation carriers: uptake and timing* AB Skytte, AM Gerdes, MK Andersen, L Sunde, K Brøndum‐Nielsen, ... Clinical genetics 77 (4), 342-349, 2010 | 121 | 2010 |
| Evaluation of the risk of persistent trophoblastic disease after twin pregnancy with diploid hydatidiform mole and coexisting normal fetus I Niemann, L Sunde, LK Petersen American Journal of Obstetrics and Gynecology 197 (1), 45. e1-45. e5, 2007 | 113 | 2007 |
| Practical clinical guidelines of the EOTTD for treatment and referral of gestational trophoblastic disease C Lok, N van Trommel, L Massuger, F Golfier, M Seckl, MH Abreu, J Attia, ... European Journal of Cancer 130, 228-240, 2020 | 105 | 2020 |
| A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma KAW Wadt, LG Aoude, P Johansson, A Solinas, A Pritchard, O Crainic, ... Clinical genetics 88 (3), 267-272, 2015 | 103 | 2015 |
Göran JönssonProfessor, Dept. of Oncology, Clinical Sciences, Lund University, SwedenVerified email at med.lu.se